Drugs / BRC-003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06523725 | Nov 2024 → Apr 2025 | post-traumatic epilepsy | Dr. Paul Lyons | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BRC-003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06523725 ↗ |
| Route | Oral | “PO BRC-003 (High Cannabidiol Cannabis Extract)” NCT06523725 ↗ |